Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Strata Skin Sciences ( (SSKN) ) has shared an update.
On September 2, 2025, Strata Skin Sciences entered into Securities Purchase Agreements with institutional investors to issue 1,097,547 shares of common stock at $2.204 per share, raising approximately $2.4 million in a registered direct offering. Ladenburg Thalmann & Co. Inc. acted as the exclusive placement agent, and the proceeds are intended for general corporate and working capital purposes. The offering is expected to close on or around September 4, 2025, and is made under a shelf registration statement filed with the SEC.
The most recent analyst rating on (SSKN) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Strata Skin Sciences stock, see the SSKN Stock Forecast page.
Spark’s Take on SSKN Stock
According to Spark, TipRanks’ AI Analyst, SSKN is a Neutral.
Strata Skin Sciences faces significant financial challenges with ongoing losses and declining equity, which heavily impact its overall score. While technical indicators show bullish momentum, the stock is overbought, and valuation metrics are weak due to negative earnings. The earnings call and corporate events provide a mixed outlook, with potential market expansion and legal risks. The company’s strategic initiatives could improve its future prospects, but current financial and compliance issues weigh heavily on its score.
To see Spark’s full report on SSKN stock, click here.
More about Strata Skin Sciences
STRATA Skin Sciences is a medical technology company focused on developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions such as psoriasis, vitiligo, and acne. Their product lineup includes the XTRAC® excimer laser, VTRAC® lamp systems, and the TheraClear®X Acne Therapy System. The company operates a unique Partnership Program in the U.S., which offers a fee per treatment cost structure, on-site training, equipment maintenance, and advertising support.
Average Trading Volume: 864,635
Technical Sentiment Signal: Sell
Current Market Cap: $9.93M
For a thorough assessment of SSKN stock, go to TipRanks’ Stock Analysis page.